Figure 3.
(A) Supervised clustering of the Germany acute myeloid leukaemia series using the S17 signature. The marked cluster of the high WT1 patients, comprising 31% of the cases, showed distinct gene expression profiling as compared to the remaining clusters. (B, C) Kaplan–Meier analysis of the survival in the Germany validation series clustered by S17 signature. Log‐Rank (Mantel–Cox) P‐values included 2·2 × 10−13 and 5·4 × 10−12 for OS (B) and RFS (C), respectively. OS, overall survival; RFS, relapse‐free survival;